ORCID
Mario Romano https://orcid.org/0000-0001-8512-1458
REFERENCES
Ariga, M., Neitzert, B., Nakae, S., Mottin, G., Bertrand, C., Pruniaux,
M.P., et al. (2004). Nonredundant function of phosphodiesterases 4D and
4B in neutrophil recruitment to the site of inflammation. J
Immunol 173 : 7531–7538.
Baye, J. (2012). Roflumilast (daliresp): a novel phosphodiesterase-4
inhibitor for the treatment of severe chronic obstructive pulmonary
disease. P T 37 : 149–161.
Blanchard, E., Zlock, L., Lao, A., Mika, D., Namkung, W., Xie, M., et
al. (2014). Anchored PDE4 regulates chloride conductance in wild-type
and ΔF508-CFTR human airway epithelia. FASEB J 28 : 791–801.
Bragonzi, A. (2010). Murine models of acute and chronic lung infection
with cystic fibrosis pathogens. Int J Med Microbiol 300 :
584–593.
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y.,
Weiss, D.S., et al. (2004). Neutrophil extracellular traps kill
bacteria. Science 303 : 1532–1535.
Bundschuh, D., Eltze, M., Barsig, J., Wollin, L., Hatzelmann, A., and
Beume, R. (2001). In Vivo Efficacy in Airway Disease Models of
Roflumilast, a Novel Orally Active PDE4 Inhibitor. J Pharmacol
ExpTher 297 : 280–90.
Cheng, O.Z., and Palaniyar, N. (2013). NET balancing: a problem in
inflammatory lung diseases. Front Immunol 4 : 1.
Cutone, A., Lepanto, M.S., Rosa, L., Scotti, M.J., Rossi, A., Ranucci,
S., et al. (2019). Aerosolized Bovine Lactoferrin Counteracts Infection,
Inflammation and Iron Dysbalance in A Cystic Fibrosis Mouse Model of
Pseudomonas aeruginosa Chronic Lung Infection. Int J Mol Sci 20 :
2028.
Davis, S.D., and Ferkol, T. (2013). Identifying the origins of cystic
fibrosis lung disease. N Engl J Med 368 : 2026–2028.
Dittrich, A.S., Kühbandner, I., Gehrig, S., Rickert-Zacharias, V.,
Twigg, M., Wege, S., et al. (2018). Elastase activity on sputum
neutrophils correlates with severity of lung disease in cystic fibrosis.Eur Respir J 51 : 1701910.
Dwyer, M., Shan, Q., D’Ortona, S., Maurer, R., Mitchell, R., Olesen, H.,
et al. (2014). Cystic fibrosis sputum DNA has NETosis characteristics
and neutrophil extracellular trap release is regulated by macrophage
migration-inhibitory factor. J Innate Immun 6 : 765–779.
Evangelista, V., Pamuklar, Z., Piccoli, A., Manarini, S., Dell’elba, G.,
Pecce, R., et al. (2007). Src family kinases mediate neutrophil adhesion
to adherent platelets. Blood 109 : 2461–2469.
Facchini, M., De Fino, I., Riva, C., and Bragonzi, A. (2014). Long term
chronic Pseudomonas aeruginosa airway infection in mice. J Vis
Exp. 17:51019.
Fuchs, T.A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M.,
Myers, D.D., et al. (2010). Extracellular DNA traps promote thrombosis.Proc Natl Acad Sci U S A 107 : 15880–15885.
Gray, R.D., Hardisty, G., Regan, K.H., Smith, M., Robb, C.T., Duffin,
R., et al. (2018). Delayed neutrophil apoptosis enhances NET formation
in cystic fibrosis. Thorax 73 : 134–144.
Hartl, D., Latzin, P., Hordijk, P., Marcos, V., Rudolph, C., Woischnik,
M., et al. (2007). Cleavage of CXCR1 on neutrophils disables bacterial
killing in cystic fibrosis lung disease. Nat Med 13 : 1423–1430.
Hohlfeld, J.M., Schoenfeld, K., Lavae-Mokhtari, M., Schaumann, F.,
Mueller, M., Bredenbroeker, D., et al. (2008). Roflumilast attenuates
pulmonary inflammation upon segmental endotoxin challenge in healthy
subjects: a randomized placebo-controlled trial. Pulm Pharmacol
Ther 21 : 616–623.
Jin, S.-L.C., and Conti, M. (2002). Induction of the cyclic nucleotide
phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses.Proc Natl Acad Sci U S A 99 : 7628–7633.
Jin, S.-L.C., Lan, L., Zoudilova, M., and Conti, M. (2005). Specific
role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in
mouse macrophages. J Immunol 175 : 1523–1531.
Kessenbrock, K., Krumbholz, M., Schönermarck, U., Back, W., Gross, W.L.,
Werb, Z., et al. (2009). Netting neutrophils in autoimmune small-vessel
vasculitis. Nat Med 15 : 623–625.
Khan, M.A., Ali, Z.S., Sweezey, N., Grasemann, H., and Palaniyar, N.
(2019). Progression of Cystic Fibrosis Lung Disease from Childhood to
Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation,
and NET Degradation. Genes (Basel) 10 : 183.
Li, M., Lin, C., Deng, H., Strnad, J., Bernabei, L., Vogl, D.T., et al.
(2020). A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5
Blocks Formation of Neutrophil Extracellular Traps and Delays
Progression of Multiple Myeloma. Mol Cancer Ther 19 : 1530–1538.
Marcos, V., Zhou-Suckow, Z., Önder Yildirim, A., Bohla, A., Hector, A.,
Vitkov, L., et al. (2015). Free DNA in Cystic Fibrosis Airway Fluids
Correlates with Airflow Obstruction.
Mediators Inflamm 2015 : 408935.
McKeon, D.J., Condliffe, A.M., Cowburn, A.S., Cadwallader, K.C., Farahi,
N., Bilton, D., et al. (2008). Prolonged survival of neutrophils from
patients with ΔF508 CFTR mutations. Thorax 63 : 660–661.
Mondal, S., and Thompson, P.R. (2019). Protein Arginine Deiminases
(PADs): Biochemistry and Chemical Biology of Protein Citrullination.Acc Chem Res 52 : 818–832.
Moriceau, S., Lenoir, G., and Witko-Sarsat, V. (2010). In Cystic
Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed
and Modulated by Diamide or Roscovitine: Evidence for an Innate
Neutrophil Disturbance. J Innate Immun 2 : 260–266.
Neeli, I., Khan, S.N., and Radic, M. (2008). Histone deimination as a
response to inflammatory stimuli in neutrophils. J Immunol 180 :
1895–1902.
Papayannopoulos, V., Metzler, K.D., Hakkim, A., and Zychlinsky, A.
(2010). Neutrophil elastase and myeloperoxidase regulate the formation
of neutrophil extracellular traps. J Cell Biol 191 : 677–691.
Paroni, M., Moalli, F., Nebuloni, M., Pasqualini, F., Bonfield, T.,
Nonis, A., et al. (2013). Response of CFTR-Deficient Mice to Long-Term
chronic Pseudomonas aeruginosa Infection and PTX3 Therapy. J
Infect Dis 208 : 130–138.
Rabe, K.F. (2011). Update on roflumilast, a phosphodiesterase 4
inhibitor for the treatment of chronic obstructive pulmonary disease. Br
J Pharmacol 163 : 53–67.
Remijsen, Q., Vanden Berghe, T., Wirawan, E., Asselbergh, B., Parthoens,
E., De Rycke, R., et al. (2011). Neutrophil extracellular trap cell
death requires both autophagy and superoxide generation. Cell Res21 : 290–304.
Rich, P., Gooderham, M., Bachelez, H., Goncalves, J., Day, R.M., Chen,
R., et al. (2016). Apremilast, an oral phosphodiesterase 4 inhibitor, in
patients with difficult-to-treat nail and scalp psoriasis: Results of 2
phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). J Am
Acad Dermatol 74: 134–142.
Sanz, M.-J., Alvarez, A., Piqueras, L., Cerdá, M., Issekutz, A.C., Lobb,
R.R., et al. (2002). Rolipram inhibits leukocyte-endothelial cell
interactions in vivo through P- and E-selectin downregulation. Br J
Pharmacol 135 : 1872–1881.
Sanz, M.J., Cortijo, J., and Morcillo, E.J. (2005). PDE4 inhibitors as
new anti-inflammatory drugs: effects on cell trafficking and cell
adhesion molecules expression. Pharmacol Ther 106 : 269–297.
Sanz, M.-J., Cortijo, J., Taha, M.A., Cerdá-Nicolás, M., Schatton, E.,
Burgbacher, B., et al. (2007). Roflumilast inhibits
leukocyte-endothelial cell interactions, expression of adhesion
molecules and microvascular permeability. Br J Pharmacol 152 :
481–492.
Schudt, C., Hatzelmann, A., Beume, R., and Tenor, H. (2011).
Phosphodiesterase inhibitors: history of pharmacology. Handb Exp
Pharmacol 1–46.
Shishikura, K., Horiuchi, T., Sakata, N., Trinh, D., Shirakawa, R.,
Kimura, T., et al. (2016). Prostaglandin E2 inhibits neutrophil
extracellular trap formation through production of cyclic AMP. Br
J Pharmacol 173 : 319–331.
Sly, P.D., Gangell, C.L., Chen, L., Ware, R.S., Ranganathan, S., Mott,
L.S., et al. (2013). Risk factors for bronchiectasis in children with
cystic fibrosis. N Engl J Med 368 : 1963–1970.
Sousa, L.P., Lopes, F., Silva, D.M., Tavares, L.P., Vieira, A.T.,
Rezende, B.M., et al. (2010). PDE4 inhibition drives resolution of
neutrophilic inflammation by inducing apoptosis in a
PKA-PI3K/Akt-dependent and NF-kappaB-independent manner. J Leukoc
Biol 87 : 895–904.
Thiam, H.R., Wong, S.L., Qiu, R., Kittisopikul, M., Vahabikashi, A.,
Goldman, A.E., et al. (2020). NETosis proceeds by cytoskeleton and
endomembrane disassembly and PAD4-mediated chromatin decondensation and
nuclear envelope rupture. Proc Natl Acad Sci U S A 117 :
7326–7337.
Tirouvanziam, R. (2006). Neutrophilic inflammation as a major
determinant in the progression of cystic fibrosis. Drug News
Perspect 19 : 609–614.
Totani, L., Amore, C., Di Santo, A., Dell’Elba, G., Piccoli, A.,
Martelli, N., et al. (2016). Roflumilast inhibits leukocyte-platelet
interactions and prevents the prothrombotic functions of
polymorphonuclear leukocytes and monocytes. J Thromb Haemost 14 :
191–204.
Totani, L., Piccoli, A., Dell’Elba, G., Amore, C., Santo, A.D.,
Martelli, N., et al. (2014). Phosphodiesterases type-4 blockade prevents
platelet-mediated neutrophil recruitment at the site of vascular injury.Arterioscler Thromb Vasc Biol 34 : 1689–1696.
Wang, Y., Li, M., Stadler, S., Correll, S., Li, P., Wang, D., et al.
(2009). Histone hypercitrullination mediates chromatin decondensation
and neutrophil extracellular trap formation. J Cell Biol 184 :
205–213.
Wedzicha, J.A., Calverley, P.M., Rabe, K.F. (2016). Roflumilast: a
review of its use in the treatment of COPD. Int J Chron Obstruct
Pulmon Dis . 11 : 81-90.
Yadav, R., Yoo, D.-G., Kahlenberg, J.M., Bridges, S.L., Oni, O., Huang,
H., et al. (2019). Systemic levels of anti-PAD4 autoantibodies correlate
with airway obstruction in cystic fibrosis. J Cyst Fibros18 : 636–645.
Young, R.L., Malcolm, K.C., Kret, J.E., Caceres, S.M., Poch, K.R.,
Nichols, D.P., et al. (2011). Neutrophil Extracellular Trap
(NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired
Resistance within the CF Airway, Independent of CFTR. PLoS One6 : e23637.
Table 1. Demographic characteristics of subjects with CF
recruited for the study.